AI-generated summary
Researchers tested transcranial 810-nm low-level laser therapy in neonatal rats with hypoxic-ischemic brain injury, measuring brain tissue changes and behavior up to 20 weeks later. The authors report less neuronal loss and glial reactivity, higher Nrf2/HO-1 and Akt signaling early on, and better motor and memory performance. They note the mechanisms of long-term effects require further investigation.
- Who or what was studied
- Neonatal rats with hypoxic-ischemic brain damage
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract describes an animal study and states that the mechanisms underlying long-term outcomes require further investigation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.